Effects of catechin on expressions of ET and NO in rats with nephrotic syndrome
何小解,易著文,何庆南,党西强,吴小川,卢向阳,方建虎
DOI: https://doi.org/10.3760/j.issn:0578-1310.2002.09.010
2002-01-01
Abstract:Objective Endothelin (ET) and nitric oxide (NO) play an important role in the occurrence and progression of renal diseases Recently their direct effects on the glomerulus have been observed Catechin is extracted from the green tea and is the main component of tea polyphenoles Catechin is a significant non enzyme anti oxidizer The anti oxidization of catechin is 20 times higher than that of vitamin E, and 6 times higher than that of superoxide dismutase (SOD) In addition, catechin shows the ability of anti agglutination and accelerating fibrinolysis In order to elucidate the partial possible mechanism of catechin on the treatment of nephrotic syndrome and the prevention of chronic renal injuries, the effect of catechin on expressions of NO and ET in plasma and renal cortex was investigated Methods Thirty six female SD rats were randomly divided into six groups, control, nephrotic, and dexamethasone treated, catechin prevented, catechin treated, and dexamethasone plus catechin treated groups At the end of the experiment, the excretion of 24 hrs urinary protein and the concentrations of the plasma and renal cortex NO were detected by means of the biochemistry assay The concentrations of the plasma and renal cortex ET were detected by means of the radioimmunoassay (RIA) The expression of PCNA in renal intrinsic cells was measured with the immunohistochemical technique A semiquantitative score was used to evaluate the injury degree of the glomeruli and tubulointerstitium Results At the end of the experiment, the concentrations of the plasma and renal cortex NO were (13 5±3 7) and (27 8±12 4) in the nephrotic group,(25 3±5 3) and (42 5±1 9)in the catechin treated group (36 8±5 3) and (55 5±15 4,) in the catechin prevented group,(43 3±4 0) and (73 6±15 8)in the dexamethasone treated group and, (54 3±7 1) and (96 4±17 2)in the dexamethasone plus catechin treated group ( F =62 3,79 4, P 0 01) While the concentrations of the plasma and renal cortex ET were (572±91) and (1 493±29) in the nephrotic group, which was the highest, (417±54) and (1 220±126) in the catechin treated, (398±76) and (1 023±134) in the catechin prevented, (300±88) and (951±235) in the dexamethasone treated and, (237±66) and (774±127) in the dexamethasone plus catechin treated groups (except P 0 05 in the catechin treated group, all others P 0 01) PCNA expressions of glomerular mesangial cells, visceral glomerular epithelial cells, glomerular endothelial cells, tublule epithelial cells and vascular endothelial cells were higher in the nephrotic group than those in the other groups (compared with the nephrotic group, P 0 05 in the catechin treated group, P 0 01 in all other groups) Compared with the nephrotic group, the renal pathologic scores were significantly different among the nephrotic group, catechin treated group (6 80±0 84, P 0 05), catechin prevented group (6 50±1 00, P 0 01), dexamethasone treated group (4 40±0 89, P 0 01), and dexamethasone plus catechin treated group (3 40±0 55 , P 0 01) The renal pathologic scores were positively correlated with the expression of PCNA, the concentrations of the plasma and renal cortex ET, the excretion of 24 hrs urinary protein ( P 0 01), and were negatively correlated with the concentrations of the plasma and renal cortex NO ( P 0 01) Conclusion Catechin slowed the chronic progressive renal lesions, which might be achieved by the increase of the renal cortex and plasma NO concentrations, the decrease of the renal cortex and plasma ET concentrations, the inhibition of the renal intrinsic cells proliferation, and the reduction of the 24 hrs urinary protein excretion